Cancer Research Cell Death Mechanisms and Cancer Therapy  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 68, 759, February 1, 2008. doi: 10.1158/0008-5472.CAN-07-5014
© 2008 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Contreras, C. M.
Right arrow Articles by Castrillon, D. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Contreras, C. M.
Right arrow Articles by Castrillon, D. H.

Cell, Tumor, and Stem Cell Biology

Loss of Lkb1 Provokes Highly Invasive Endometrial Adenocarcinomas

Cristina M. Contreras1,2, Sushma Gurumurthy5, J. Marshall Haynie1,2, Lane J. Shirley1,2, Esra A. Akbay1,2, Shana N. Wingo3, John O. Schorge2,3,4, Russell R. Broaddus7, Kwok-Kin Wong6, Nabeel Bardeesy5 and Diego H. Castrillon1,2

1 Department of Pathology, 2 Simmons Comprehensive Cancer Center, 3 Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, and 4 Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas; 5 Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School; 6 Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts; and 7 Department of Pathology, M. D. Anderson Cancer Center, Houston, Texas

Requests for reprints: Diego H. Castrillon, University of Texas Southwestern Medical Center, Department of Pathology, 6000 Harry Hines Boulevard, Dallas, TX 75390-9072. Phone: 214-648-4032; Fax: 214-648-7355; E-mail: diego.castrillon{at}utsouthwestern.edu.

Key Words: Endometrial cancer • Lkb1 • invasion • cell polarity

Mutations in the LKB1 tumor suppressor gene result in the Peutz-Jeghers syndrome, an autosomal dominant condition characterized by hamartomatous polyps of the gastrointestinal tract and a dramatically increased risk of epithelial malignancies at other sites, including the female reproductive tract. Here we show that female mice heterozygous for a null Lkb1 allele spontaneously develop highly invasive endometrial adenocarcinomas. To prove that these lesions were indeed due to Lkb1 inactivation, we introduced an adenoviral Cre vector into the uterine lumen of mice harboring a conditional allele of Lkb1. This endometrial-specific deletion of the Lkb1 gene provoked highly invasive and sometimes metastatic endometrial adenocarcinomas closely resembling those observed in Lkb1 heterozygotes. Tumors were extremely well differentiated and histopathologically distinctive and exhibited alterations in AMP-dependent kinase signaling. Although Lkb1 has been implicated in the establishment of cell polarity, and loss of polarity defines most endometrial cancers, Lkb1-driven endometrial cancers paradoxically exhibit (given their highly invasive phenotype) normal cell polarity and apical differentiation. In human endometrial cancers, Lkb1 expression was inversely correlated with tumor grade and stage, arguing that Lkb1 inactivation or down-regulation also contributes to endometrial cancer progression in women. This study shows that Lkb1 plays an important role in the malignant transformation of endometrium and that Lkb1 loss promotes a highly invasive phenotype. [Cancer Res 2008;68(3):759–66]




This article has been cited by other articles:


Home page
Sci SignalHome page
H. Cheng, P. Liu, Z. C. Wang, L. Zou, S. Santiago, V. Garbitt, O. V. Gjoerup, J. D. Iglehart, A. Miron, A. L. Richardson, et al.
SIK1 Couples LKB1 to p53-Dependent Anoikis and Suppresses Metastasis
Sci. Signal., July 21, 2009; 2(80): ra35 - ra35.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
M. Jansen, J. P. ten Klooster, G. J. Offerhaus, and H. Clevers
LKB1 and AMPK Family Signaling: The Intimate Link Between Cell Polarity and Energy Metabolism
Physiol Rev, July 1, 2009; 89(3): 777 - 798.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
G. R. Steinberg and B. E. Kemp
AMPK in Health and Disease
Physiol Rev, July 1, 2009; 89(3): 1025 - 1078.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Rodriguez-Nieto and M. Sanchez-Cespedes
BRG1 and LKB1: tales of two tumor suppressor genes on chromosome 19p and lung cancer
Carcinogenesis, April 1, 2009; 30(4): 547 - 554.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
R. G. Jones and C. B. Thompson
Tumor suppressors and cell metabolism: a recipe for cancer growth
Genes & Dev., March 1, 2009; 23(5): 537 - 548.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2008 by the American Association for Cancer Research.